Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 03-May-24
Select bar for recommendation details.
Recommendations | 03-May-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 2 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast
The 7 analysts offering 12 month price targets for Alliance Pharma plc have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 42.00. The median estimate represents a 81.27% increase from the last price of 33.10.
High | 171.9% | 90.00 |
Med | 81.3% | 60.00 |
Low | 26.9% | 42.00 |
Dividends
Div growth (TTM) | 5.03% |
---|
More ▼
Earnings history & estimates
Average growth rate | +1.40% |
More ▼
Revenue history & estimates
Average growth rate | +9.69% |
More ▼